W. Scott Harkonen, M.D., is President and Chief Executive Officer of CoMentis, a pharmaceutical company engaged in the discovery and development of small-molecule drugs to treat Alzheimer’s disease, age-related macular degeneration (AMD) and cognitive disorders.

(more…)

Dr. Steven Targum serves as Chief Medical Officer at BrainCells, Inc. (BCI), a biopharmaceutical company focused on the development of breakthrough small molecule therapeutics for diseases of the central nervous system (CNS).  (more…)

I just sat down at my computer and answered 298 questions about myself as part of a career development assessment. The questions were straightforward, and the process only took about 45 minutes. Now I am waiting for the results, intrigued and a bit intimidated by what I might find out about myself. (more…)

Martin Tolar, M.D., Ph.D., is Chief Scientific Officer at CoMentis, a pharmaceutical company engaged in the discovery and development of small-molecule drugs to treat Alzheimer’s disease, age-related macular degeneration (AMD) and cognitive disorders. (more…)

Dr. Yamada joined Frazier Healthcare Ventures in 2006 as a Senior Advisor to the biopharma team. (more…)

Henry Hsu, M.D., Chief Medical Officer, CoMentis, a pharmaceutical company engaged in the discovery and development of small-molecule drugs to treat Alzheimer’s disease, age-related macular degeneration (AMD) and cognitive disorders. (more…)

August M. Watanabe, MD, joined Frazier Healthcare Ventures in 2005 as Senior Advisor to the Biopharma team.   (more…)